Last 12 months
Inside the activity.
6 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 2 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 16, 2006 Filed Aug 18, 2006 16:20 UTC |
Fiorentino Edward JSenior Vice President
|
Exercise / conversionCommon shares without par value | 2,831 | $43.99 | $124,528.33 |
DisclosureSEC source: 0001104659-06-056024 · a4.xml · nonDerivative · entry 3 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,428 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2006 Filed Aug 18, 2006 16:20 UTC |
Fiorentino Edward JSenior Vice President
|
Exercise / conversionCommon shares without par value | 5,553 | $39.92 | $221,691.31 |
DisclosureSEC source: 0001104659-06-056024 · a4.xml · nonDerivative · entry 2 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,597 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2006 Filed Aug 18, 2006 16:20 UTC |
Fiorentino Edward JSenior Vice President
|
Exercise / conversionCommon shares without par value | 2,875 | $34.77 | $99,971.51 |
DisclosureSEC source: 0001104659-06-056024 · a4.xml · nonDerivative · entry 1 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,044 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2006 Filed Aug 17, 2006 18:53 UTC |
Tyree James LSenior Vice President
|
GrantOption (right to buy) · Derivative | 3,782 | $0.00 Strike: $47.96 | $0.00 |
DisclosureSEC source: 0001104659-06-055799 · a4.xml · derivative · entry 11 Tyree James L · CIK 0001324991 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,782 Underlying: common shares · 3,782 shares Expires 2013-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 15, 2006 Filed Aug 17, 2006 18:53 UTC |
Tyree James LSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 3,180 | $0.00 Strike: $44.32 | $0.00 |
DisclosureSEC source: 0001104659-06-055799 · a4.xml · derivative · entry 10 Tyree James L · CIK 0001324991 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 3,180 shares Expires 2007-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 15, 2006 Filed Aug 17, 2006 18:53 UTC |
Tyree James LSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,468 | $0.00 Strike: $40.51 | $0.00 |
DisclosureSEC source: 0001104659-06-055799 · a4.xml · derivative · entry 9 Tyree James L · CIK 0001324991 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 2,468 shares Expires 2007-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 15, 2006 Filed Aug 17, 2006 18:53 UTC |
Tyree James LSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,519 | $0.00 Strike: $39.68 | $0.00 |
DisclosureSEC source: 0001104659-06-055799 · a4.xml · derivative · entry 8 Tyree James L · CIK 0001324991 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 2,519 shares Expires 2007-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 15, 2006 Filed Aug 17, 2006 18:53 UTC |
Tyree James LSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 5,100 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-06-055799 · a4.xml · derivative · entry 7 Tyree James L · CIK 0001324991 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 5,100 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 15, 2006 Filed Aug 17, 2006 18:53 UTC |
Tyree James LSenior Vice President
|
Tax withholdingCommon shares without par value | 11,308 | $47.96 | $542,331.68 |
DisclosureSEC source: 0001104659-06-055799 · a4.xml · nonDerivative · entry 5 Tyree James L · CIK 0001324991 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,365 Read SEC document |
| August 15, 2006 Filed Aug 17, 2006 18:53 UTC |
Tyree James LSenior Vice President
|
Exercise / conversionCommon shares without par value | 3,180 | $44.32 | $140,940.78 |
DisclosureSEC source: 0001104659-06-055799 · a4.xml · nonDerivative · entry 4 Tyree James L · CIK 0001324991 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,673 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2006 Filed Aug 17, 2006 18:53 UTC |
Tyree James LSenior Vice President
|
Exercise / conversionCommon shares without par value | 2,468 | $40.51 | $99,967.33 |
DisclosureSEC source: 0001104659-06-055799 · a4.xml · nonDerivative · entry 3 Tyree James L · CIK 0001324991 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,493 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2006 Filed Aug 17, 2006 18:53 UTC |
Tyree James LSenior Vice President
|
Exercise / conversionCommon shares without par value | 2,519 | $39.68 | $99,949.89 |
DisclosureSEC source: 0001104659-06-055799 · a4.xml · nonDerivative · entry 2 Tyree James L · CIK 0001324991 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,025 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2006 Filed Aug 17, 2006 18:53 UTC |
Tyree James LSenior Vice President
|
Exercise / conversionCommon shares without par value | 5,100 | $33.23 | $169,480.14 |
DisclosureSEC source: 0001104659-06-055799 · a4.xml · nonDerivative · entry 1 Tyree James L · CIK 0001324991 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,506 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 02, 2006 Filed Aug 3, 2006 22:25 UTC |
NEMMERS JOSEPH MExecutive Vice President
|
SaleCommon shares without par value | 10,000 | $47.00 | $470,000.00 |
DisclosureSEC source: 0001104659-06-051249 · a4.xml · nonDerivative · entry 1 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,397 Read SEC document |
| August 01, 2006 Filed Aug 3, 2006 22:27 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
Tax withholdingCommon shares without par value | 3,156 | $47.35 | $149,420.82 |
DisclosureSEC source: 0001104659-06-051250 · a4.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,986 Read SEC document |
| July 31, 2006 Filed Aug 2, 2006 22:46 UTC |
Fussell Stephen RSenior Vice President
|
GrantOption (right to buy) · Derivative | 11,876 | $0.00 Strike: $47.82 | $0.00 |
DisclosureSEC source: 0001104659-06-050795 · a4.xml · derivative · entry 11 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,876 Underlying: Common shares · 11,876 shares Expires 2013-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| July 31, 2006 Filed Aug 2, 2006 22:46 UTC |
Fussell Stephen RSenior Vice President
|
GrantOption (right to buy) · Derivative | 3,003 | $0.00 Strike: $47.82 | $0.00 |
DisclosureSEC source: 0001104659-06-050795 · a4.xml · derivative · entry 10 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,003 Underlying: Common shares · 3,003 shares Expires 2010-02-10 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| July 31, 2006 Filed Aug 2, 2006 22:46 UTC |
Fussell Stephen RSenior Vice President
|
GrantOption (right to buy) · Derivative | 1,304 | $0.00 Strike: $47.82 | $0.00 |
DisclosureSEC source: 0001104659-06-050795 · a4.xml · derivative · entry 9 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,304 Underlying: Common shares · 1,304 shares Expires 2007-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| July 31, 2006 Filed Aug 2, 2006 22:46 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 14,567 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-06-050795 · a4.xml · derivative · entry 8 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,635 Underlying: Common shares · 14,567 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| July 31, 2006 Filed Aug 2, 2006 22:46 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 3,720 | $0.00 Strike: $32.61 | $0.00 |
DisclosureSEC source: 0001104659-06-050795 · a4.xml · derivative · entry 7 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,065 Underlying: Common shares · 3,720 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| July 31, 2006 Filed Aug 2, 2006 22:46 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,274 | $0.00 Strike: $27.43 | $0.00 |
DisclosureSEC source: 0001104659-06-050795 · a4.xml · derivative · entry 6 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 2,274 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| July 31, 2006 Filed Aug 2, 2006 22:46 UTC |
Fussell Stephen RSenior Vice President
|
Tax withholdingCommon shares without par value | 16,183 | $47.82 | $773,871.06 |
DisclosureSEC source: 0001104659-06-050795 · a4.xml · nonDerivative · entry 4 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,539 Read SEC document |
| July 31, 2006 Filed Aug 2, 2006 22:46 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionCommon shares without par value | 14,567 | $33.23 | $484,081.80 |
DisclosureSEC source: 0001104659-06-050795 · a4.xml · nonDerivative · entry 3 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,722 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2006 Filed Aug 2, 2006 22:46 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionCommon shares without par value | 3,720 | $32.61 | $121,313.29 |
DisclosureSEC source: 0001104659-06-050795 · a4.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,155 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2006 Filed Aug 2, 2006 22:46 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionCommon shares without par value | 2,274 | $27.43 | $62,382.19 |
DisclosureSEC source: 0001104659-06-050795 · a4.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,435 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2006 Filed Sep 14, 2006 18:57 UTC Amendment |
Fussell Stephen RSenior Vice President
|
GrantOption (right to buy) · Derivative | 11,636 | $0.00 Strike: $47.82 | $0.00 |
DisclosureSEC source: 0001104659-06-061116 · a4a.xml · derivative · entry 3 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,636 Underlying: Common shares · 11,636 shares Expires 2013-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. F1 · kind: Due to an administrative error, the number of shares previously reported as having been used to pay for his July 31 exercises and the number of shares granted as replacement options with respect to those exercises were incorrect. This Form 4 reports the correct numbers. Read SEC document |
| July 31, 2006 Filed Sep 14, 2006 18:57 UTC Amendment |
Fussell Stephen RSenior Vice President
|
GrantOption (right to buy) · Derivative | 2,885 | $0.00 Strike: $47.82 | $0.00 |
DisclosureSEC source: 0001104659-06-061116 · a4a.xml · derivative · entry 2 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,885 Underlying: Common shares · 2,885 shares Expires 2010-02-10 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. F1 · kind: Due to an administrative error, the number of shares previously reported as having been used to pay for his July 31 exercises and the number of shares granted as replacement options with respect to those exercises were incorrect. This Form 4 reports the correct numbers. Read SEC document |
| July 31, 2006 Filed Sep 14, 2006 18:57 UTC Amendment |
Fussell Stephen RSenior Vice President
|
Tax withholdingCommon shares without par value | 15,825 | $47.82 | $756,751.50 |
DisclosureSEC source: 0001104659-06-061116 · a4a.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,897 F1 · kind: Due to an administrative error, the number of shares previously reported as having been used to pay for his July 31 exercises and the number of shares granted as replacement options with respect to those exercises were incorrect. This Form 4 reports the correct numbers. Read SEC document |
| July 27, 2006 Filed Jul 31, 2006 21:21 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GrantOption (right to buy) · Derivative | 273,778 | $0.00 Strike: $47.10 | $0.00 |
DisclosureSEC source: 0001104659-06-049984 · a4.xml · derivative · entry 14 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,778 Underlying: common shares · 273,778 shares Expires 2013-02-13 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| July 27, 2006 Filed Jul 31, 2006 21:21 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GrantOption (right to buy) · Derivative | 39,457 | $0.00 Strike: $47.10 | $0.00 |
DisclosureSEC source: 0001104659-06-049984 · a4.xml · derivative · entry 13 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,457 Underlying: common shares · 39,457 shares Expires 2010-02-10 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| July 27, 2006 Filed Jul 31, 2006 21:21 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GrantOption (right to buy) · Derivative | 2,122 | $0.00 Strike: $47.10 | $0.00 |
DisclosureSEC source: 0001104659-06-049984 · a4.xml · derivative · entry 12 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,122 Underlying: common shares · 2,122 shares Expires 2010-02-10 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| July 27, 2006 Filed Jul 31, 2006 21:21 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GrantOption (right to buy) · Derivative | 2,121 | $0.00 Strike: $47.10 | $0.00 |
DisclosureSEC source: 0001104659-06-049984 · a4.xml · derivative · entry 11 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,121 Underlying: common shares · 2,121 shares Expires 2007-02-13 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| July 27, 2006 Filed Jul 31, 2006 21:21 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Exercise / conversionOption (right to buy) · Derivative | 333,181 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-06-049984 · a4.xml · derivative · entry 10 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 342,493 Underlying: common shares · 333,181 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| July 27, 2006 Filed Jul 31, 2006 21:21 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Exercise / conversionOption (right to buy) · Derivative | 51,553 | $0.00 Strike: $32.61 | $0.00 |
DisclosureSEC source: 0001104659-06-049984 · a4.xml · derivative · entry 9 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 51,553 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| July 27, 2006 Filed Jul 31, 2006 21:21 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Exercise / conversionOption (right to buy) · Derivative | 3,643 | $0.00 Strike: $27.43 | $0.00 |
DisclosureSEC source: 0001104659-06-049984 · a4.xml · derivative · entry 8 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 3,643 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| July 27, 2006 Filed Jul 31, 2006 21:21 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Tax withholdingCommon shares without par value | 317,478 | $47.10 | $14,953,213.80 |
DisclosureSEC source: 0001104659-06-049984 · a4.xml · nonDerivative · entry 4 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 833,199 Read SEC document |
| July 27, 2006 Filed Jul 31, 2006 21:21 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Exercise / conversionCommon shares without par value | 333,181 | $33.23 | $11,072,071.08 |
DisclosureSEC source: 0001104659-06-049984 · a4.xml · nonDerivative · entry 3 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,150,677 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2006 Filed Jul 31, 2006 21:21 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Exercise / conversionCommon shares without par value | 51,553 | $32.61 | $1,681,200.04 |
DisclosureSEC source: 0001104659-06-049984 · a4.xml · nonDerivative · entry 2 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 817,496 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2006 Filed Jul 31, 2006 21:21 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Exercise / conversionCommon shares without par value | 3,643 | $27.43 | $99,937.69 |
DisclosureSEC source: 0001104659-06-049984 · a4.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 765,943 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 26, 2006 Filed Jul 27, 2006 22:30 UTC |
Tyree James LSenior Vice President
|
SaleCommon shares without par value | 320 | $47.50 | $15,200.00 |
DisclosureSEC source: 0001104659-06-049374 · a4.xml · nonDerivative · entry 1 Tyree James L · CIK 0001324991 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,406 Read SEC document |
| July 25, 2006 Filed Jul 27, 2006 21:02 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,355 | $0.00 Strike: $42.42 | $0.00 |
DisclosureSEC source: 0001104659-06-049351 · a4.xml · derivative · entry 9 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 2,355 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| July 25, 2006 Filed Jul 27, 2006 21:02 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 4,073 | $0.00 Strike: $41.97 | $0.00 |
DisclosureSEC source: 0001104659-06-049351 · a4.xml · derivative · entry 8 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 4.073 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| July 25, 2006 Filed Jul 27, 2006 21:02 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Tax withholdingCommon shares without par value | 5,984 | $47.56 | $284,599.04 |
DisclosureSEC source: 0001104659-06-049351 · a4.xml · nonDerivative · entry 3 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,187 Read SEC document |
| July 25, 2006 Filed Jul 27, 2006 21:02 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionCommon shares without par value | 2,355 | $42.42 | $99,905.22 |
DisclosureSEC source: 0001104659-06-049351 · a4.xml · nonDerivative · entry 2 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,171 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 25, 2006 Filed Jul 27, 2006 21:02 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionCommon shares without par value | 4,073 | $41.97 | $170,949.92 |
DisclosureSEC source: 0001104659-06-049351 · a4.xml · nonDerivative · entry 1 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,816 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 25, 2006 Filed Jul 27, 2006 22:29 UTC |
REYNOLDS W ANNDirector
|
Exercise / conversionOption (right to buy) · Derivative | 1,796 | $0.00 Strike: $24.20 | $0.00 |
DisclosureSEC source: 0001104659-06-049373 · a4.xml · derivative · entry 5 REYNOLDS W ANN · CIK 0001018652 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 1,796 shares Expires 2006-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| July 25, 2006 Filed Jul 27, 2006 22:29 UTC |
REYNOLDS W ANNDirector
|
SaleCommon shares without par value | 1,796 | $48.00 | $86,208.00 |
DisclosureSEC source: 0001104659-06-049373 · a4.xml · nonDerivative · entry 2 REYNOLDS W ANN · CIK 0001018652 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,002 Read SEC document |
| July 25, 2006 Filed Jul 27, 2006 22:29 UTC |
REYNOLDS W ANNDirector
|
Exercise / conversionCommon shares without par value | 1,796 | $24.20 | $43,463.02 |
DisclosureSEC source: 0001104659-06-049373 · a4.xml · nonDerivative · entry 1 REYNOLDS W ANN · CIK 0001018652 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,798 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 19, 2006 Filed Jul 21, 2006 21:15 UTC |
REYNOLDS W ANNDirector
|
Exercise / conversionOption (right to buy) · Derivative | 1,870 | $0.00 Strike: $23.23 | $0.00 |
DisclosureSEC source: 0001104659-06-048259 · a4.xml · derivative · entry 5 REYNOLDS W ANN · CIK 0001018652 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 1,870 shares Expires 2006-09-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| July 19, 2006 Filed Jul 21, 2006 21:15 UTC |
REYNOLDS W ANNDirector
|
SaleCommon shares without par value | 1,870 | $45.00 | $84,150.00 |
DisclosureSEC source: 0001104659-06-048259 · a4.xml · nonDerivative · entry 2 REYNOLDS W ANN · CIK 0001018652 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,002 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.